Biotech planning operates in a world where the consequences of failure are extreme. Patient outcomes are at stake, volumes are low but risks are high, and regulation embeds constraints into every decision.
Traditional planning models were never designed for this reality. Yet many biotech organizations still rely on reactive, spreadsheet-driven processes that hide risk, delay critical decisions, and amplify complexity. As volatility and regulatory pressure increase, this approach is no longer sustainable.
In this webinar, discover how forward-thinking biotech leaders are transforming planning from reactive firefighting to proactive, scenario-driven control. Learn how modern planning platforms are enabling faster decisions, clearer trade-offs, and resilient operations in highly regulated environments.
You’ll learn about:
Global Head of Strategic Growth at Bluecrux
Hendrik drives strategic growth across sales, partnerships, and product commercialization by leading and coaching commercial teams for scalable performance, supporting complex enterprise deals through executive alignment and solution development, accelerating global SaaS rollouts, and strengthening key alliances, including the global partnership with Anaplan.
VP, GM of Applications (EMEA) and Global Supply Chain Lead at Anaplan
Emily is a seasoned supply chain and technology expert. Her career began in the defence sector, where she witnessed the challenges of managing intricate supply chains. This experience sparked a passion for transforming supply chain operations. Her expertise lies in driving innovation and enabling sustainable growth by breaking down silos and fostering alignment across teams. Passionate about the intersection of technology and supply chain, Emily is a recognized thought leader, frequently sharing insights on how advanced analytics and scenario planning can help organizations navigate uncertainty and stay resilient.